Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 91 AL 105

Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis

Soysal P, Isik AT, Stubbs B, Solmi M, Volpe M, Luchini C, D'Onofrio G, Pilotto A, Manzato E, Sergi G, Schofield P, Veronese N.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1368-1374. doi: 10.1136/jnnp-2016-313660. Epub 2016 Jun 3.

BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides

Choi RJ, Roy A, Jung HJ, Ali MY, Min BS, Park CH, Yokozawa T, Fan TP, Choi JS, Jung HA.

J Ethnopharmacol. 2016 Aug 22;190:219-30. doi: 10.1016/j.jep.2016.06.013. Epub 2016 Jun 5.

Common therapeutic strategies for prion and Alzheimer's diseases

Elezgarai SR, Biasini E.

Biol Chem. 2016 Nov 1;397(11):1115-1124. doi: 10.1515/hsz-2016-0190.

Essential Oils and Pure Volatile Compounds as Potential Drugs in Alzheimer's Disease Therapy: An Updated Review of the Literature

Maggio A, Rosselli S, Bruno M.

Curr Pharm Des. 2016;22(26):4011-27. doi: 10.2174/1381612822666160607065917.

Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Xiao T, Jiao B, Zhang W, Tang B, Shen L.

CNS Drugs. 2016 Oct;30(10):899-907. doi: 10.1007/s40263-016-0356-1.

Pharmacogenetic considerations in the treatment of Alzheimer's disease

Cacabelos R, Torrellas C, Teijido O, Carril JC.

Pharmacogenomics. 2016 Jun;17(9):1041-74. doi: 10.2217/pgs-2016-0031. Epub 2016 Jun 13.

Low-Level Laser Therapy to the Bone Marrow Ameliorates Neurodegenerative Disease Progression in a Mouse Model of Alzheimer's Disease: A Minireview

Oron A, Oron U.

Photomed Laser Surg. 2016 Dec;34(12):627-630. doi: 10.1089/pho.2015.4072. Epub 2016 Jun 13.

Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review)

Li X, Bao X, Wang R.

Mol Med Rep. 2016 Aug;14(2):1043-53. doi: 10.3892/mmr.2016.5390. Epub 2016 Jun 10.

Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?

Pivovarova O, Höhn A, Grune T, Pfeiffer AF, Rudovich N.

Ann Med. 2016 Dec;48(8):614-624. doi: 10.1080/07853890.2016.1197416. Epub 2016 Jun 19.

Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases

Jung HA, Ali MY, Jung HJ, Jeong HO, Chung HY, Choi JS.

J Ethnopharmacol. 2016 Sep 15;191:152-160. doi: 10.1016/j.jep.2016.06.037. Epub 2016 Jun 15.

Alzheimer's disease, menopause and the impact of the estrogenic environment

Pines A.

Climacteric. 2016 Oct;19(5):430-2. doi: 10.1080/13697137.2016.1201319. Epub 2016 Jun 21.

Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine

Cardoso S, Carvalho C, Correia SC, Seiça RM, Moreira PI.

Brain Pathol. 2016 Sep;26(5):632-47. doi: 10.1111/bpa.12402.

Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease

Bernardo TC, Marques-Aleixo I, Beleza J, Oliveira PJ, Ascensão A, Magalhães J.

Brain Pathol. 2016 Sep;26(5):648-63. doi: 10.1111/bpa.12403.

Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence

Yamazaki Y, Painter MM, Bu G, Kanekiyo T.

CNS Drugs. 2016 Sep;30(9):773-89. doi: 10.1007/s40263-016-0361-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias